Print

Injectable Contraceptive Users Have Increased VTE Risk, Leiden University Medical Center Study  
10/26/2010 10:23:35 AM

MedWire News: Users of the injectable contraceptive depot-medroxyprogesterone acetate (DMPA) are nearly four times more likely to develop venous thromboembolism (VTE) than nonusers of hormonal contraceptives, study findings indicate.
//-->